Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
The University of Texas MD Anderson Cancer Center · Kettering University · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,258
total citations
- FWCI
- 55.48
- Percentile
- 100%
- References
- 61
Citations per year
Authors
11- SCSpencer C. WeiCorresponding
The University of Texas MD Anderson Cancer Center
- JLJacob Levine
Kettering University
- APAlexandria P. Cogdill
The University of Texas MD Anderson Cancer Center
- YZYang Zhao
The University of Texas MD Anderson Cancer Center
- NANana-Ama A.S. Anang
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- Blockade
- Biology
- Immune checkpoint
- CTLA-4
- Mass cytometry
- Cancer research
- PD-L1
- Nivolumab
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- AAstraZeneca
- CPCancer Prevention and Research Institute of TexasAwards: P30CA016672 39, R1203
- MSMeso Scale Diagnostics
- PIParker Institute for Cancer Immunotherapy
- JTJounce Therapeutics
- NINational Institutes of HealthAwards: R01CA164729, DP1-HD084071, P30CA008748, R01CA163793
- NCNational Cancer InstituteAward: P30CA016672